Children With Cancer and COVID: Most Do Well, Which Ones Don't?

A new study that followed 131 children with cancer who were infected with SARS-CoV-2 shows that most (79%) did well and had only asymptomatic or mild disease.

'Remarkable' Results in Pediatric Acute Promyelocytic Leukemia

"Remarkable" results with a novel treatment regimen in pediatric acute promyelocytic leukemia have been reported by researchers at the National Cancer Institute.

FDA Nods for Adjuvant Pembrolizumab in Kidney Cancer

Pembrolizumab has been granted approval from the US FDA for use as an adjuvant treatment following surgery in certain patients with RCC, making it the first immunotherapy to have this indication.

Surgery Offers Best Chance in Cancer but Needs More 'Support'

Surgery offers the best chance of a cure for patients with early cancer and is fundamental to cancer management, but it does not receive enough political and financial recognition.

Drug Used to Prolong Gestation Linked to Increased Cancer Risk in Offspring

A new study suggests children exposed in utero to 17 alpha-hydroxyprogesterone caproate may be at increased risk for cancer. 

Urine Test for Prostate Cancer Signals Amount of Aggressive Tumor

A potential new urine biomarker for prostate cancer not only spots the presence of aggressive tumors, it also indicates the amount of these tumors, according to a recent report.

Results With De-escalated Radiotherapy for HPV+ve Oral Cancer

New results from a phase 3 trial (MC1275) show that DART results in robust responses and lower toxicity as compared with standard care radiotherapy. 

Updated NCCN Guidelines Now Include Zanubrutinib for WM

The updated guidelines for management of WM from the NCCN now include the second-generation product zanubrutinib, which was approved for the treatment of this disease just a month ago.

Success of HPV Vaccination: 'Dramatic' Reduction in Cervical Cancer

Among young women who received the HPV vaccine when they were 12 or 13 years old (before their sexual debut), cervical cancer rates are 87% lower than among previous nonvaccinated generations.

HYPORT in Prostate Cancer: New Standard After Surgery?

The long-term side effects of HYPORT for prostate cancer are similar to those of conventional radiotherapy, a new study concludes.

Subscribe to Medscape

source list reference

rgb(171, 222, 222)
rgb(219, 18, 118)
200, 66, 245
rgb(195, 2, 230)
rgb (247, 7, 79)
rgb(14, 133, 237)
rgb(252, 3, 223)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(252, 186, 3)
rgb(242, 0, 137)
rgb (247, 7, 79)
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
rgb (252, 186, 3)
rgb(156, 242, 7)
rgb(91, 128, 189)
rgb(247, 139, 109)
rgb(224, 4, 129)
rgb(20, 13, 222)
rgb(84, 54, 94)
rgb(80, 147, 199)
rgb(117, 2, 247)
rgb(153, 146, 129)
rgb (245, 152, 2)
rgb(169, 196, 201)
rgb(5, 235, 235)
rgb(235, 190, 9)
rgb(209, 227, 11)
200, 66, 245
rgb (191, 171, 145)
rgb(126, 14, 237)
rbg(167, 124, 235)
rgb (132, 101, 173)
rbg(16, 162, 230)
rgb(217, 7, 192)
rgb(224, 224, 4)
rgb(2, 230, 230)
rgb(235, 64, 52)